They identified the small molecule LH846 after a Luciferase cell-based assay of 500 000 compounds. The probe was then functionalized with a PEG linker and used in pull-down assays, they identified casein kinase 1 delta (CKIdelta) as the target. This is a known protein kinase that regulates the circadian clock. LH846 is a relatively potent and selective CKIdelta inhibitor that could provide insights into the role of circadian rhythms as well as new treatments for circadian disorders.
No comments:
Post a Comment